Ad is loading...
AXON
Price
$631.27
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
101 days until earnings call
CGEN
Price
$1.45
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
89 days until earnings call
Ad is loading...

AXON vs CGEN

Header iconAXON vs CGEN Comparison
Open Charts AXON vs CGENBanner chart's image
Axon Enterprise
Price$631.27
Change-$0.00 (-0.00%)
Volume$885.47K
CapitalizationN/A
Compugen
Price$1.45
Change-$0.00 (-0.00%)
Volume$145.84K
CapitalizationN/A
AXON vs CGEN Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AXON vs. CGEN commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Buy and CGEN is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (AXON: $636.95 vs. CGEN: $1.41)
Brand notoriety: AXON and CGEN are both not notable
AXON represents the Aerospace & Defense, while CGEN is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 88% vs. CGEN: 117%
Market capitalization -- AXON: $48.57B vs. CGEN: $127.76M
AXON [@Aerospace & Defense] is valued at $48.57B. CGEN’s [@Biotechnology] market capitalization is $127.76M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $196.06B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $14.51B. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 3 FA rating(s) are green whileCGEN’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 3 green, 2 red.
  • CGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than CGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while CGEN’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 4 bearish.
  • CGEN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AXON is a better buy in the short-term than CGEN.

Price Growth

AXON (@Aerospace & Defense) experienced а +6.27% price change this week, while CGEN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +4.44%. For the same industry, the average monthly price growth was +5.98%, and the average quarterly price growth was +15.01%.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

AXON is expected to report earnings on Mar 04, 2025.

CGEN is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Aerospace & Defense (+4.44% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($48.6B) has a higher market cap than CGEN($128M). AXON has higher P/E ratio than CGEN: AXON (165.44) vs CGEN (47.00). AXON YTD gains are higher at: 146.564 vs. CGEN (-28.788). AXON has higher annual earnings (EBITDA): 408M vs. CGEN (10.6M). AXON has more cash in the bank: 1.16B vs. CGEN (113M). CGEN has less debt than AXON: CGEN (2.95M) vs AXON (721M). AXON has higher revenues than CGEN: AXON (1.94B) vs CGEN (59.9M).
AXONCGENAXON / CGEN
Capitalization48.6B128M37,969%
EBITDA408M10.6M3,849%
Gain YTD146.564-28.788-509%
P/E Ratio165.4447.00352%
Revenue1.94B59.9M3,239%
Total Cash1.16B113M1,025%
Total Debt721M2.95M24,457%
FUNDAMENTALS RATINGS
AXON vs CGEN: Fundamental Ratings
AXON
CGEN
OUTLOOK RATING
1..100
2552
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
2100
SMR RATING
1..100
5386
PRICE GROWTH RATING
1..100
160
P/E GROWTH RATING
1..100
3072
SEASONALITY SCORE
1..100
n/a20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CGEN's Valuation (74) in the Biotechnology industry is in the same range as AXON (94). This means that CGEN’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (2) in the Biotechnology industry is significantly better than the same rating for CGEN (100). This means that AXON’s stock grew significantly faster than CGEN’s over the last 12 months.

AXON's SMR Rating (53) in the Biotechnology industry is somewhat better than the same rating for CGEN (86). This means that AXON’s stock grew somewhat faster than CGEN’s over the last 12 months.

AXON's Price Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for CGEN (60). This means that AXON’s stock grew somewhat faster than CGEN’s over the last 12 months.

AXON's P/E Growth Rating (30) in the Biotechnology industry is somewhat better than the same rating for CGEN (72). This means that AXON’s stock grew somewhat faster than CGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONCGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 23 days ago
67%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FJTSY17.880.15
+0.85%
Fujitsu Ltd.
BLGO0.18N/A
-0.28%
BioLargo, Inc.
LSRCY22.44-0.15
-0.66%
Lasertec Corp.
TCEHY51.20-1.00
-1.92%
Tencent Holding Ltd.
THNPY23.87-1.07
-4.27%
Technip Energies NV

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with NURPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then NURPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
-2.76%
NURPF - CGEN
46%
Loosely correlated
-9.14%
ASPHF - CGEN
41%
Loosely correlated
N/A
ORMP - CGEN
40%
Loosely correlated
+1.30%
CYTK - CGEN
38%
Loosely correlated
+3.00%
AXON - CGEN
36%
Loosely correlated
+0.90%
More